Buddy Creech

Jens Meiler, Distinguished Research Professor of Chemistry, was named the principal investigator for the project, in cooperation with 14 investigators across eight institutions. The team will work together to use advanced technology, including computational modeling, AI-driven predictions and structural biology, to develop a groundbreaking vaccine against all alphaviruses that offers long-lasting protection. Read More

A Vanderbilt study finds that Moderna’s COVID-19 vaccine is safe and effective in children 6 months to 5 years of age. Read More

Moderna’s COVID-19 vaccine is safe and generates robust immune responses in children ages 6 to 11 years, a national clinical trial co-led by C. Buddy Creech, MD, MPH, has found. Read More

Vanderbilt University Medical Center has begun recruiting up to 250 participants for a Phase 3 clinical trial testing an investigational COVID-19 vaccine candidate developed by the Janssen Pharmaceutical Companies of Johnson & Johnson. Read More

The investigational antiviral drug remdesivir can shorten the time to recovery in adults hospitalized with COVID-19, according to preliminary results of a clinical trial published last month in The New England Journal of Medicine. Read More

Buddy Creech, director, Vanderbilt Vaccine Research Program, is helping lead some of the NIH-funded treatment trials of COVID-19 in hospitalized patients at Vanderbilt University Medical Center. Read More

Vanderbilt researchers led by Buddy Creech are searching for the key to lasting protection against influenza by examining naturally protecting cells found in bone marrow. Read More

Vanderbilt University Medical Center is recruiting volunteers to participate in a national study of an investigational vaccine against the H7N9 influenza virus, also known as “bird flu.” Read More

Researchers at Vanderbilt University Medical Center are leading an international effort to develop a universal influenza vaccine that would protect everyone against all strains of the flu anywhere in the world. Read More

New multicenter research that includes Vanderbilt University Medical Center (VUMC) investigators, could change treatment approaches to simple skin abscesses, infections often caused by Staphylococcus aureus (staph) bacteria. Read More

Researchers at Vanderbilt University Medical Center (VUMC) are leading a multicenter clinical trial to evaluate whether a shorter course of antibiotics — five days instead of 10 — is effective at treating community-acquired pneumonia (CAP) in children who show improvement after the first few days of taking antibiotics. Read More

The National Institutes of Health (NIH) is launching its Voices of the NIH Community website, which features a collection of StoryCorps audio recordings from patients, families, researchers, doctors, nurses, staff and volunteers in both the NIH and Vanderbilt University Medical Center (VUMC) communities. Read More

Buddy Creech, M.D., MPH, associate professor of Pediatrics, has been named director of the Vanderbilt Vaccine Research Program (VVRP) in the Division of Pediatric Infectious Diseases. Read More

Antibiotic-resistant bacteria can share resources to cause chronic infections, Vanderbilt investigators have discovered. The findings shed light on a long-standing question in infectious diseases and may inform new treatment strategies. Read More

College athletes who play contact sports are more than twice as likely to carry the deadly superbug methicillin-resistant Staphylocuccus aureus (MRSA) than peers who play non-contact sports, according to a Vanderbilt study released at IDWeek 2014. Read More

The Vanderbilt Vaccine Research Program has received a major contract from the National Institutes of Health to continue its work as one of the nation’s Vaccine and Treatment Evaluation Units. Read More

Vanderbilt University Medical Center has been selected by the Centers for Disease Control and Prevention (CDC), to lead a consortium of top national experts in vaccine safety in performing timely reviews of adverse vaccine events. Read More

Vanderbilt pediatric infectious disease researchers studying antibiotic-resistant staph say fears that mothers carrying the germ may set their newborns up for infection are unfounded. Read More

This Week on VUCast: Why a Vanderbilt disease expert says the medical thriller “Contagion” may be closer to reality than you think [ watch full video of Dr. Creech and more information about vaccines ] Why it’s worth going to… Read More

Researchers at Vanderbilt find less commonly prescribed drug is more effective in treating MRSA skin infections in children. Read More